We characterized dopamine toxicity in human neuroblastoma SH-SY5Y cells as a direct effect of dopamine on cell reductive power, measured as NADH and NADPH cell content. In cell incubations with 100 or 500 μM dopamine, the accumulation of dopamine inside the cell reached a maximum after 6 h. The decrease in cell viability was 40% and 75%, respectively, after 24 h, and was not altered by MAO inhibition with tranylcypromine. Dopamine was metabolized to DOPAC by mitochondrial MAO and, at 500 μM concentration, significantly reduced mitochondrial potential and oxygen consumption. This DA concentration caused only a slight increase in cell peroxidation in the absence of Fe(III), but a dramatic decrease in NADH and NADPH cell content and a concomitant decrease in total cell NAD(P)H/NAD(P) + and GSH/GSSG and in mitochondrial NADH/NAD + ratios. Dopaminechrome, a product of dopamine oxidation, was found to be a MAO-A inhibitor and a strong oxidizer of NADH and NADPH in a cell-free system. We conclude that dopamine may affect NADH and NADPH oxidation directly. When the intracellular concentrations of NAD(P)H and oxidized dopamine are similar, NAD(P)H triggers a redox cycle with dopamine that leads to its own consumption. The time-course of NADH and NADPH oxidation by dopamine was assessed in cell-free assays: NAD(P)H concentration decreased at the same time as dopamine oxidation advanced. The break in cell redox equilibrium, not excluding the involvement of free oxygen radicals, could be sufficient to explain the toxicity of dopamine in dopaminergic neurons.
Introduction
Although dopamine (DA) is the main neurotransmitter of the nigrostriatal pathway and its loss is the main neurochemical parameter in Parkinson's disease, DA itself has often been suspected of having a function in the genesis of dopaminergic neurodegeneration. The potential toxicity of DA has been studied and described in several cell models, such as chick embryo sympathetic neurons [61] , primary nigral, forebrain and striatal rat cultures [26, 39, 41] , SH-SY5Y human neuroblastoma cells [34] and PC12 cells [29] , with the aim of clarifying the apparent "dopamine paradox" [11, 55] .
It is commonly assumed that DA triggers cell oxidative stress by its own enzymatic oxidation by monoamine oxidase (MAO) or, like 6-OHDA toxicity, through its non-enzymatic, pH-dependent autoxidation. In both cases it generates H 2 O 2 , which causes cell oxidative stress, and increases lipid and protein peroxidation [7, 33] . Dihydroxyphenylacetic acid (DOPAC) is the main product of MAO metabolism, and DA autoxidation gives different oxidized products with at least 4 electrochemical peaks between 0.21 and 0.29 V at pH 7 (increasing 65 mV/pH unit [16] ), among them dopaminequinone, dopaminechrome and products of condensation, which finally yield neuromelanin [17] . Quinones may react with cysteine residues, modify protein structures [35] and induce DNAdamage [54] and thus apoptosis [23] . However, it has also been reported that, due to its redox properties, DA may act as a reducing/ antioxidant agent and so, at least at low concentrations, have a beneficial effect on neuron plasticity and survival [53, 56] . The oxidative stress caused by DA may be strongly linked to the DA concentrations inside the cell and to the collateral effects on compounds with a potentially higher reduction potential.
Several authors, using isolated mitochondria, describe the effect of DA on mitochondrial respiration [6, 8, 21, 36, 42] , or a strengthening of the MPP + effect by DA [12] . Although the effect of DA beyond its action as a neurotransmitter has often been questioned and even considered an artifact [14] , experience shows that cells with high DA concentrations, such as dopaminergic neurons, are highly vulnerable to degeneration. The DA paradox is the subject of a number of studies, which have lead to the hypothesis that an imbalance between cytosolic and vesicular DA switches on a process that leads to neuron degeneration [5] .
Human neuroblastoma SH-SY5Y cells can be used to study DA cytotoxicity due to their dopaminergic characteristics [44] . Apoptotic [30] , necrotic and autophagic [21] cell death has been described in these cells after incubation with DA. At present, all the effects described by DA on SH-SY5Y cells are prevented by antioxidants of intracellular action [21] , which indicates that the damage caused by DA is mediated by its oxidation or by its oxidized products.
The mechanisms of degeneration of DA neurons in the substantia nigra of Parkinson's disease patients have not yet been shown conclusively. Neurons dying by apoptosis, autophagy or non-defined death forms have been described [2] . We present data indicating that non-vesiculated DA, when it achieves high intracellular concentrations, may overcome the antioxidant capacity of the cell, thus directly interfering in cell redox potential and inducing cell damage.
Material and methods

Cell Culture
SH-SY5Y cells (kindly provided by Dr. J. Comella, University of Lleida, Spain) were grown in Dulbecco's Modified Eagle Medium (DMEM, Gibco BRL, Paisley, UK), supplemented with 10% fetal bovine serum (Gibco BRL), 100 U/ml penicillin and 100 μg/ml streptomycin. Cells were maintained in a humidified 10% CO 2 atmosphere at 37°C. Experiments were performed in 6-or 12-well culture plates at~80% cell confluence.
Compounds
Dopamine (DA) was purchased from Sigma (St. Louis, MO) and added to the medium at a final concentration of 100 or 500 μM. Dihydroxyphenylacetic acid (DOPAC), tert-butylhydroperoxide (tBOOH), reduced (GSH) and oxidized (GSSG) glutathione, NADH and NADPH, and tranylcypromine (TCP) were from Sigma. FeCl 3 was from Merck. Dopaminechrome (DAchr) was prepared from DA with sodium periodate (20 mM, Sigma) in a 20 mM Tris buffer at pH 6.8 and room temperature, following the procedure described in [3] . [7,8- 3 H]-DA and [ 3 H]-thymidine were from Amersham Biosciences, GmbH Europe (Barcelona, Spain). Proteins were determined by the BCA™ assay (Pierce, Rockford, IL). All the reagents were of analytical grade except for HPLC analysis, in which reagents were of HPLC grade.
DA-uptake
Cells were incubated in 1 ml of DMEM with different final concentrations of DA (0, 50, 100, 250, 500 μM), containing 10 nCi/μmol of [7, H]-DA, for different times up to 24 h. To measure DAchr uptake, the radio-labeled DA was previously oxidized as indicated above. The cells were washed three times in DMEM, after which no significant radioactivity was detected in the medium, and lysed with 0.5 ml of 1% SDS. Radioactivity was determined by liquid scintillation counting as cpm per mg of protein and values were corrected to be expressed as pmol/mg prot. ]thymidine (1 μCi/ml; 1 mM) and 0, 100 or 500 μM DA. After different times, cultures were washed in phosphate buffered saline (PBS) and the cells were lysed with trichloroacetic acid (TCA) for 30 min at 4°C. TCA was then removed and the cell lysates were washed in ethanol and extracted in 0.5 ml of 2% Na 2 CO 3 , 0.1 M NaOH, 1% SDS. Tritium incorporation was determined by liquid scintillation counting.
Acridine orange
Cell viability was determined with acridine orange/ethidium bromide (1:1) by microscopy fluorescence. Living cells incorporate acridine and become green, whereas damaged or dead cells are stained orange-red by ethidium bromide.
MTT
3-(4,5-dimethylthiozol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; RBI) is converted in living cells by reduction into insoluble formazan, whose amount is proportional to the number of viable cells. Cells (5 × 10 5 ) were incubated for 2 h at 37°C with 0.5 mg/ml MTT. The cells were washed and lysed with an equal volume of isopropanol/HCl (1 M) (24:1). Reduced MTT was measured at 550 nm in a 96-microtiter plate.
Peroxidation measurements
After incubation in a range of conditions, the cell were washed twice in HSSB (NaCl 135 mM, KCl 5 mM, CaCl 2 1.8 mM, MgSO 4 0.62 mM, HEPES 10 mM) and incubated with 10 μM 2′,7′-dichlorofluorescein diacetate (DCFH-DA, Sigma) for 30 min. Cells were washed twice in HSSB, and cellular fluorescence intensity was measured in a Microtiter Fluorescence Plate Reader (Biorad) at 485 nm excitation and 538 nm emission.
Mitochondrial potential
Changes in mitochondrial function were determined by analyzing the mitochondrial potential (ΔΨ m ) by cytometry. 10 6 cells were incubated with 4 μg/ml JC-1 (Molecular Probes) for 45 min at 37°C in DMEM without serum. Cells were scored using a FACScalibur flow cytometer and data were analyzed on Cellquest Pro software by measurement of both green (530 ± 15 nm, FL-1) and orange (585 ± 21 nm, FL-2) JC-1 fluorescence. The loss in ΔΨ m is seen as a shift to lower JC-1 orange fluorescence accompanied by an increase in JC-1 green fluorescence. At least 10,000 events were collected per sample.
Oxygen consumption
After DA treatment, SH-SY5Y cultures were rinsed twice with PBS, trypsinized and counted. Cell suspensions were adjusted to 10 5 cells/ml with DMEM. Cell respiration was measured at 37°C and 750 rpm stirring speed in an Oxygraph highresolution respirometer with DatLab software for data acquisition and analysis (Oroboros, Innsbruck, Austria). Extra-mitochondrial oxygen consumption was measured on addition of 20 μM antimycin A. Results were standardized in relation to the actual protein content in the measuring chambers.
DA and DOPAC quantification
Cells were lysed with 0.4 M HClO 4 and centrifuged for 10 min (12,000×g). DA and DOPAC were determined in the supernatants (after filtering with 0.4 μm pore-size Millipore HV filters) by HPLC (LKB-Pharmacia) with electrochemical detection (Coulochem II, ESA). A nucleosil C-18 reverse-phase column (5 μm, 250 × 4.6 mm, Tracer) was used. The mobile phase consisted of 50 mM sodium acetate, 25 mM citric acid, 0.7 mM octanesulfonic acid and 10% methanol at pH 4.1, filtered with 0.2 μm pore-size Millipore filters and degassed. A dual electrochemical detector was used with E1 = + 50 mV and E2 = + 300 mV at the analytical cell.
MAO activity
MAO-A activity was determined radiochemically, with 14 C-labeled substrate as previously described [18] . Briefly, mitochondrial fractions were prepared by differential centrifuging [20] 
. GSH/GSSG
We used a modified OPA assay procedure [51] . 4×10 5 cells were plated and, after various treatments, were washed twice in ice-cold PBS. Cells were lysed with 1 ml of lysis buffer (20 mM HCl, 5 mM DTPA, 10 mM ascorbic acid and 5% HClO 4 ) and the suspensions were centrifuged at 12,000×g for 10 min at 4°C. The resulting supernatant solutions were centrifuged again for 5 min through a 0.45-μm microcentrifuge filter (Millipore, Bedford, MA, USA). The filtered supernatants were used to determine GSH and GSSG levels by fluorescence (Shimadzu spectrofluorimeter) after o-phthaldialdehyde (OPA) derivatization.
Cellular NADH and NADPH
NADH and NADPH total cell content was determined by HPLC. Cells were extracted in alkaline medium to avoid the oxidation of NAD(P)H with 0.5% Nonidet P-40 buffer containing KOH at pH 9.0. The cell lysates were centrifuged at 3,000 rpm for 5 min at 4°C and the supernatants immediately filtered through 0.4 μm pore-size Millipore HV filters. Reverse-phase HPLC was performed with a Nucleosyl-C18 (5 μm, Tracer) column on a Pharmacia-LKB HPLC. The mobile phase was 50 mM sodium acetate (pH 8.0 with KOH) and 15% methanol at 1 ml/min flow rate. NADH and NADPH peaks were monitored with a UV detector (Pharmacia-LKB) at 340 nm.
The total NAD + and the cytoplasm NAD + content were determined in hydrazineglycine buffer (0.3 M hydrazine sulfate, 0.87 M glycine, 0.19 mM EDTA pH 9.5), with 12 U/ml LDH, using 2 mM lactate as a substrate, after acidic lysis of the cells with 3% HClO 4 , centrifugation and neutralization of the supernatant, or in a cytosolic fraction after separation of membranes and organelles. The cytosolic fraction was obtained from trypsinized cells lysed with a buffer containing: 25 mM Tris, 200 mM sucrose, 1 mM EDTA, 0.05% digitonin, 1 mM DTT, 0.1 mM PMSF, 1 μg/ml of leupeptin, pepstatin, aprotinin, benzamidine. The cells homogenates were centrifuged at 15,700×g and the supernatants were collected as cytosolic fractions. Cytoplasmic NADH was deduced from cytoplasmic NAD + and the cytoplasmic.
] ratio. The difference between total and cytoplasm contents, both relating to the total protein cell content, was used to estimate NAD + and NADH mitochondrial contents.
Pyruvate/lactate and NADH/NAD
+ ratio measurements in cells Extracts were obtained by washing the cells twice in phosphate-buffered saline (PBS) and then scraping the cell layer in 0.1 ml of PBS with 0.1 ml of HClO 4 at 6%. It was then centrifuged at 13,000 rpm for 10 min at 4°C. Supernatant was neutralized with 3 M NaOH. Pyruvate in 100 μl of extract was measured with 100 μl of a reaction mixture containing 40 μM NADH, 0.3 U/ml of lactate dehydrogenase (LDH) in 50 mM imidazole buffer, pH 7.0. After 15 min at room temperature, 40 μl of 0.1 M HCl was added and the mixture heated to 60°C for 15 min. 75 μl of 12 M NaOH was added and the mixture heated again to 60°C for 15 min. The fluorescence of the mixture was measured with a Fluorimeter at 355 nm excitation and 440 nm emission. Lactate (Lac) concentration was measured by a procedure described elsewhere [25] 
In vitro NAD(P)H and DA oxidation
NADH and NADPH and oxidation were measured in vitro in cell-free solutions containing 100 μM NADH or NADPH and varying DA or DAchr concentrations, in 0.1 M PBS buffer (pH 7.4) and in 96-well microtiter plates, by following the absorbance of these solutions at 340 nm. DA oxidation was analyzed in the same solutions at 492 nm. The effect of 5 mM GSH, 1 mM FeCl 3 (Fe(III)) or both was also assessed by this procedure. 
Statistical analysis
The significances of differences between groups were analyzed by ANOVA and the Scheffé test.
Results
The study of the uptake of [7, H] DA by the cell revealed that DA, at concentrations of 100 and 500 μM (DA-100 and DA-500), accumulates in the cell in a fast and concentrationdependent manner, reaching an intracellular maximum after about 6 h (Fig. 1A) . The concentrations of DA, or derived compounds, found inside the cell after 24 h were approximately 80 μM and 270 μM for respectively DA-100 and DA-500 (taking protein and water content as 15% and 70% of cell weight). The amount of autoxidized DA in a culture medium at 37°C was determined in vitro by HPLC and electrochemical detection measuring the decrease in total DA. The decrease was linear over time and was established at 15 ± 1% after 24 h, so that the real extracellular reduced DA concentrations were 85 and 425 μM at that time respectively for DA-100 and DA-500. Labeled DAchr, the main autoxidation product of DA, was detected inside the cell only when 500 μM concentrations were used, but not at concentrations under 100 μM, which could be achieved by extracellular DA autoxidation (Fig. 1B) .
In order to establish how the intracellular accumulation of DA affects cell proliferation and viability, these parameters were measured by different procedures. Cell proliferation was studied by [ 3 H]-thymidine incorporation in a starting number of 30,000 cells with or without DA up to 24 h of incubation. Fig. 2 shows that cell proliferation was not affected by DA-100, but was dramatically decreased by DA-500. The viability of SH-SY5Y was detected by two different procedures. Fluorescence microscopy with orange acridine plus ethidium bromide also showed no significant damage with DA-100, but 56% of cells incubated with DA-500 were unviable after 24 h (Fig. 3A, B) . However, the viability of the cell cultures, measured by the MTT procedure, was reduced to 60% and 25% of un-treated controls after 24 h incubation with, respectively, DA-100 and DA-500 (Fig. 3C) . The addition of a non-specific MAO inhibitor, 1 mM tranylcypromine (TCP) [12] , did not alter the effect of DA-500 and reduced by 10% the effect of DA-100. The effect of DA-500, measured at 24 h, was reversible if DA was removed after 1 h, but not if DA was removed after 3 h or more (Fig. 3D) .
The rate of enzymatic metabolization of intracellular DA by mitochondrial MAO was assessed by measuring the content of its main metabolite, DOPAC. DA-100 was metabolized to DOPAC after 24 h, providing a DOPAC concentration of about 600 pmol/mg prot. DA content in non-treated controls was about 3 pmol/mg prot (similar results in neuroblastoma cells were reported by other authors [40, 44] ). As indicated in Table 1 , the DOPAC/DA ratio was similar in controls and DA-100, but very much lower with DA-500. The increase in DA was not due to extracellular DA, because the medium was washed until no DA was detected. Thus, this increase could indicate MAO saturation, inhibition or both.
Considering that intracellular DA may also be oxidized nonenzymatically to DAchr, we examined the effect of DAchr on MAO activity. For this purpose MAO-A activity (the main isoform described in SH-SY5Y cells [59] ) was measured using isolated mitochondria and serotonin as substrate in the presence of different concentrations of DAchr. MAO-A activity was inhibited by DAchr, with an IC 50 49 μM (Fig. 4) .
The mitochondrial activity was assessed by measuring the oxygen consumption and membrane potential. Cell oxygen consumption, determined by a respirometer, was reduced to 60% after 6 h and to less than 20% after 24 h of incubation with DA-500 (Fig. 5) . No significant changes were found with DA-100. Mitochondrial membrane potential (Δψm) was also significantly reduced to 40% after 24 h of DA-500 incubation (Fig. 6) , as determined by flow cytometry using JC-1 as fluorescent marker for mitochondrial function.
The autoxidation of DA and the reduction of mitochondrial activity could lead to an increase in H 2 O 2 production and consequently to oxidative stress. The oxidative stress caused by DA was assessed by DCFH fluorescence, essentially a measurement of cell peroxidation. It was compared with the effect of a strong peroxidative agent, tert-butylhydroperoxide (tBOOH, 100 μM), which increased fluorescence intensity nearly 3-fold in 2 h, before significantly reducing cell viability (at longer time-periods this tBOOH concentration was very cytotoxic). In this short period, DA-500 increased DCFH fluorescence by only 50%, unless 1 mM Fe(III) was added to the medium as a DA oxidation catalyser. In addition, DA acted as an antioxidant against tBOOH, blocking its effect (Fig. 7A ). Up to 24 h DA-500 alone increased significantly, but not dramatically, cell peroxidation (nearly 75%), whereas the addition of Fe(III) increased DCFH fluorescence nearly 5-fold (Fig. 7B) . Fe(III) alone, unlike Fe(II), had no effect on DCFH values (not shown). The cell viability at 24 h equally decreased with DA and with DA plus 1 mM Fe(III) (Fig. 7C) .
All these results, especially the decrease in cell viability measured by MTT, which was greater than the decrease assessed by other procedures (Figs. 2-4) , suggested that redox cell equilibrium, in terms of NADH and NADPH (NAD(P)H), should be studied after DA treatment. In cell cultures with DA-500, both NADPH and NADH contents, determined by HPLC, dropped significantly, to 75% and 50% respectively, after 6 h of incubation and dropped severely to 50% and under 20% after 24 h. This effect was maintained even when DA was removed after 6 h. NADH and NADPH content also fell significantly by 20% after 24 h of incubation with DA-100 (Fig. 8) . The reductive power of the cell is given mainly by the ratio between reduced NADH and oxidized NAD + forms in the mitochondria and, to a lesser extent, in the cytoplasm. The ratio between NADH and NAD+ in cell cytoplasm was determined from the lactate/pyruvate measurements (Table 2 ) [4, 10] . The ratio [NADPH]/[NADP + ] is usually considered to be proportional to the ratio between reduced (GSH) and oxidized (GSSG) forms of glutathione [1] . As Table 2 [10] .
The effect of DA on NAD(P)H oxidation was studied in a cell-free system by analysis of the disappearance of NAD(P)H at 340 nm and the oxidation of DA at 492 nm. Very similar results were obtained with NADH and NADPH (not shown). The NAD(P)H content (100 μM) decreased rapidly in the presence of DA. The loss of NAD(P)H was faster when incubated with DAchr instead of DA (Fig. 9A) . The effect of 500 μM DA increased with 1 mM Fe(III) and was counteracted by 5 mM GSH, whereas the addition of both Fe(III) and GSH gave only partial protection (Fig. 9B) . The oxidation of DA proceeded slowly when NAD(P)H was present in the medium. DA oxidation abruptly increased as NAD(P)H decreased (Fig.  9C) . The antioxidant effect of NADH on DA oxidation (492 nm reading) was confirmed by incubating 500 μM DA with 5 mM NADH at room temperature (not shown).
Discussion
The cytotoxicity of DA is described basically at the extracellular concentrations of 100 and 500 μM (DA-100 and DA-500). These concentrations could be considered above the physiological range, since DA extracellular concentrations in substantia nigra or striatum are far lower, of the order of nM, as microdialysis procedures show [49] . The striatal concentration of DA is, however, estimated to be about 70 μM, whereas the dopaminergic concentration in the neuronal endings is of the order of mM [15, 32] and the synaptic concentration of DA during the phasic release has also been established as being of the order of mM [58] . The purpose of this study was to describe the effects of non-vesiculated intracellular DA in a range of concentrations that could be achieved intracellularly if DA was not efficiently stored in vesicles or if vesicles were disrupted.
We show that DA, at high enough concentrations, enters and accumulates in SH-SY5Y cells, as has been reported for other neuroblastoma cell lines [48] . This entry is probably mediated by transporters with low affinity for DA (for instance, noradrenaline transporter [50] ) or by non-receptor mediated endocytosis [43] , since the expression of the DA transporter (DAT) [37] and the rate of transport at saturating concentrations (10 μM DA) are very low in these cells (about 2 pmol/mg/min [28] ). Moreover, DAT inhibitors [21] or inhibitors of the organic cation transporter (OCT, results not shown) only partially prevent the effects of DA.
The highest DA concentration (DA-500) had antiproliferative and cytotoxic effects on SH-SY5Y cells (its effect on cell differentiation is currently being explored in our lab), which corroborates results of other authors [46] . This effect is not receptor-mediated, because the SH-SY5Y cells express DA The values are the mean ± S.E.M. for 3 measurements. Significance was *P < 0.05, **P < 0.01, ***P < 0.001 compared with non-treated control cells.
receptors only after differentiation with retinoic acid (unpublished result from our group). DA-100 was not sufficient in our model to decrease cell proliferation or viability, respectively measured by [ 3 H]-thymidine uptake and acridine orange plus ethidium bromide, but it did decrease MTT measurements by 40% [21, 34] . The discrepancy between these results may be attributable to the differences in the procedures. Whereas ethidium bromide does not dye the cell while membrane integrity is preserved, MTT is a very sensitive parameter of cell reductive power, reflecting the mitochondrial function and also the redox status of the cytoplasm [9] . Results by MTT probably overestimate the effect of DA on cell viability, indicating overall redox alteration even when cell viability is still preserved, as with DA-100.
The effect of DA on cell viability can be attributed mainly to the DA accumulated inside the cell. Although a direct effect of extracellular DA on membrane integrity cannot be ruled out, we think it irrelevant for several reasons: higher membrane lipid peroxidation reflected in DCFH measurements would be expected; DA maintained its effect on cell viability at 24 h even when it was removed after 3 h of incubation; the extracellular H 2 O 2 concentrations described in cell incubations with 500 μM DA are about 5 μM [24] , which is not toxic for SH-SY5Y cells (results not shown). In addition, we have shown that the incorporation to the medium of an extracellular antioxidant such as catalase does not protect against DA toxicity [21, 23] .
The inhibition of MAO activity with TCP has only a slight protective effect (10%) at DA-100, which exonerates this as the main mechanism responsible for DA toxicity. Assuming that the first step in DA-mediated toxicity is non-enzymatic, the increased peroxidation caused by DA-500 was relatively small compared with that caused by 100 μM of tBOOH, and it increased dramatically only when 1 mM Fe(III) was present in the medium as a DA oxidation catalyser. However, the addition of iron did not increase the damage caused by DA on cell viability, indicating that the increase of peroxidation is not the main factor responsible for cell death. Some authors have even reported that the addition of iron to the cell cultures may protect against DA toxicity [27] . However, Fe(III) increases the rate of DA oxidation in the extracellular space (Fe(III), contrarily to Fe(II) does not enter easily into the cell). It may thus decrease the DA uptake by the cell, since the uptake of DAchr is very low, as we show in Fig. 1 . In addition, the DCFH increase caused by tBOOH is greatly reduced by DA, confirming that DA plays an antioxidant role in the presence of highly oxidant compounds [53] .
MAO actively metabolizes DA-100, giving approximate intracellular concentrations for DOPAC and DA at 24 h that can be deduced from Table 1 as, respectively, 90 and 7 μM. At this concentration, the cell antioxidant mechanism may be enough to minimize the toxic effect of DA. With DA-500 treatment a large amount of DA remains unmetabolized (about 160 μM), indicating saturation or inhibition of MAO. As we showed here, one of the main products of DA autoxidation, DAchr, strongly The results are the mean ± S.E.M. for 3 different experiments. ⁎ P < 0.05. ⁎⁎ P < 0.001 compared with controls (CT). ⁎⁎⁎ P < 0.01. Fig. 9 . Experiments in 0.1 M PBS buffered cell-free system. (A) Decrease of absorbance at 340 nm in a solution containing 100 μM NADH alone (CT, white circles), and 100 μM NADH plus 100 μM DA (black circles), 500 μM DA (black squares), 100 μM DAchr (gray circles) or 500 μM DAchr (gray squares); (B) Decrease of absorbance at 340 nm in a solution containing 100 μM NADH alone (CT, white circles), and 100 μM NADH plus 500 μM DA+5mM GSH (white squares), 500 μM DA + 1 mM FeCl 3 (black squares), 500 μM DA + 5 mM GSH + 1 mM FeCl 3 (black rhombs). (C) Increase in absorbance at 492 nm (dopamine oxidation) of 100 μM DA (white circles), 500 μM DA (white squares), 100 μM DA + 100 μM NADH (black circles), 500 μM DA + 100 μM NADH (black squares), 500 μM DA + 5 mM GSH (white triangles) and 500 μM DA + 1 mM FeCl 3 (gray squares).
inhibits MAO-A activity, the main isoform in neuroblastoma cells [57] . The IC 50 of 49 μM for MAO-A inhibition by DAchr might be achieved in the mitochondria after 24 h of DA-500 incubation. MAO inhibition contributes to free DA accumulation, but prevents enzymatic H 2 O 2 production and may reduce oxidative stress and enhance cell viability, as assessed using DA-100 plus TCP.
In previous studies [21, 22] we concluded that DA-500 induced cytoplasmic damage, reflected by grp-78 induction and the presence of numerous autophagic processes, while the plasmatic and nuclear membranes were preserved. We found no staining or morphological evidence of mitochondrial alterations [21] . However, the more precise measurements described in the present study now indicate that DA does alter normal mitochondria function. The effect of DA goes beyond MAO inhibition. Cell oxygen consumption was reduced to 20% and the mitochondrial potential was reduced to 50% by DA-500 after 24 h. DA has already been described elsewhere as reducing oxygen consumption in free mitochondria suspensions, with a bypass of electrons from complex I to DAchr being one of the mechanisms involved [6, 19, 62] . It is worth remarking that DA is much more easily oxidized in a slightly basic medium, like that found in the mitochondrial matrix (pH 7.9-8.0).
NADH and NADPH measurements indicate that DA-500 significantly decreases the cell reductive power (as already suggested by MTT assays). This effect was maintained at 24 h even if DA was removed after 6 h, indicating that intracellular DA caused permanent changes. The lack of availability of H supply from NADH mainly affected mitochondria, causing a hypoxic-like condition and a decrease in aerobic ATP production [6] [4, 10] . However, the pyruvate concentration drops significantly in DA-500 treatment, indicating that pyruvate is probably still used in the mitochondria to compensate for unsuccessful NADH consumption. The addition of 1 mM of either pyruvate or lactate did not counteract the loss of viability (not shown). In the case of NADPH, the cytoplasmic and mitochondrial concentrations are usually similar, and the main source is the pentose phosphate pathway, which is not increased under hypoxic conditions.
All the intracellular antioxidant systems play a decisive role in DA oxidation and toxicity. In fact, ascorbic acid and Nacetylcysteine, at concentrations high enough to increase their intracellular content, prevent DA toxicity [21] . We still have no clear explanation as to why cell GSH does not prevent DA toxicity. The presence of a DA oxidation catalyst, such as 1 mM Fe(III), increased DA oxidation and the fall in NAD(P)H and partially counteracted GSH antioxidant action. Such a high concentration of iron is indeed found in substantia nigra [60] . Moreover, the antioxidant action of GSH depends on the [GSH]/[GSSG] ratio. In a cell culture with DA-100 or DA-500, the ratio [GSH]/[GSSG] decreases from 10 to 6 and 4, respectively. This is mainly due to an accumulation of oxidized GSSG, whereas synthesis of the reduced form GSH, which could be decreased by NADP + accumulation and by covalent trapping by dopaminequinone, is up-regulated, at least with DA-100 [23] The reduction potential for the conversion of DA to dopaminequinone has been established as E°= −0.240 V [52] . The reduction potentials of NADH and NADPH are, respectively, E°= −0.320 and −0.322 V. Given these values and considering that NADH concentrations (between 50 and 100 μM) are similar to or lower than DA intracellular concentrations after the treatment, it was assessed in a cell-free buffered system that DA-100 and DA-500 oxidize equimolar NAD(P)H concentrations in a non-enzymatic way. For approximately 12 h, 100 μM NAD(P)H prevents DA-100 oxidation, acting as an intracellular antioxidant. Although NAD(P)H is not usually considered to be a directly operating antioxidant, it has been demonstrated that NAD(P)H is a decisive antioxidant compound of major importance in mitochondria compartment [31] . The following sequence of reactions can be deduced from our data and the redox potentials: DA + O 2 ↔ DAox (indicating different forms of DA-oxidized compounds), NAD(P)H + DAox ↔ NAD(P) + + DA.
NAD(P)H oxidizes in the presence of oxidized DA (dopaminequinone, DAchr), thereby regenerating reduced DA in a cycle that depletes the cell of NADH and NADPH (Fig. 10) , until NAD(P)H concentration decreases and DA autoxidation may proceed freely. By this mechanism DA could act as an antioxidant, but oxidized DA would be responsible for the loss of NAD(P)H and, hence, of reductive power. The death program in which cytoplasmic and mitochondrial structures are involved could originate in this redox process. If mitochondria function is sufficiently preserved so as not to start an apoptotic program, the NADPH decrease in the cytoplasm may lead to autophagy [21] , as in starvation. The two mechanisms are not mutually exclusive [30] and a recent study demonstrated that inhibition of autophagy leads to apoptosis [13] .
These results strongly support the view that cells accumulating DA, mainly dopaminergic neurons of the nigrostriatal pathway, are at high risk when antioxidant systems or any mechanism preventing DA increase in cytoplasm (e.g. vesicular amine transporters) decay. Earlier studies suggested that a toxic effect of intracellular DA not linked to its oxidation cannot be excluded [45, 57] . However, the process described here could be sufficient to explain the loss of ATP and ionic homeostasis leading to cell death. Different effects on protein activation and expression have been described as caused by DA, involving p38, c-Jun, C/EBPß, GADD153, p53 or α-synuclein [22, 38, 47] . All these effects are blocked by antioxidants, and may thus have their origin in DA oxidation. In conclusion, the oxidation of DA leads to a decrease in [ 
